Pathobiology of severe asthma

Severe asthma (SA) afflicts a heterogeneous group of asthma patients who exhibit poor responses to traditional asthma medications. SA patients likely represent 5-10% of all asthma patients; however, they have a higher economic burden when compared with milder asthmatics. Considerable research has been performed on pathological pathways and structural changes associated with SA. Although limitations of the pathological approaches, ranging from sampling, to quantitative assessments, to heterogeneity of disease, have prevented a more definitive understanding of the underlying pathobiology, studies linking pathology to molecular markers to targeted therapies are beginning to solidify the identification of select molecular phenotypes. This review addresses the pathobiology of SA and discusses the current limitations of studies, the inflammatory cells and pathways linked to emerging phenotypes, and the structural and remodeling changes associated with severe disease. In all cases, an effort is made to link pathological findings to specific clinical/molecular phenotypes.

Medienart:

E-Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Annual review of pathology - 10(2015) vom: 16., Seite 511-45

Sprache:

Englisch

Beteiligte Personen:

Trejo Bittar, Humberto E [VerfasserIn]
Yousem, Samuel A [VerfasserIn]
Wenzel, Sally E [VerfasserIn]

Links:

Volltext

Themen:

Airway
Epithelium
Histology
Inflammation
Interleukins
Journal Article
Pathology
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

Anmerkungen:

Date Completed 05.06.2015

Date Revised 08.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1146/annurev-pathol-012414-040343

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM243788983